Sofinnova Investments, Inc.

Sofinnova Investments, Inc. reported 67 holdings worth US$2.3B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Sofinnova Investments, Inc. reported 67 holdings worth US$2.3B as of Sep 30, 2026. Largest: Natera, Inc., Genmab A/S and Vera Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
67
Value as reported
US$2.3B

The filing in full

CompanySharesValue as reported% of portfolio
Natera, Inc.1.55MUS$641M27.8%
Genmab A/S4.35MUS$155M6.7%
Vera Therapeutics, Inc.2.79MUS$90.2M3.9%
Axsome Therapeutics, Inc.446KUS$82.2M3.6%
Seaport Therapeutics, Inc.3.56MUS$71.9M3.1%
Rapport Therapeutics, Inc.1.9MUS$64M2.8%
ArriVent BioPharma, Inc.1.7MUS$51.4M2.2%
Rhythm Pharmaceuticals, Inc.535KUS$50.9M2.2%
Eli Lilly and Company43,777US$50.7M2.2%
Dyne Therapeutics, Inc.2.51MUS$40.5M1.8%
Inhibrx Biosciences, Inc.392KUS$39.2M1.7%
IDEAYA Biosciences, Inc.946KUS$36.4M1.6%
Immunome, Inc.1.63MUS$35M1.5%
Novartis AG197KUS$28M1.2%
Alnylam Pharmaceuticals, Inc.113KUS$27.9M1.2%
Ultragenyx Pharmaceutical Inc.1.75MUS$26.4M1.1%
BioMarin Pharmaceutical Inc.433KUS$26M1.1%
Bristol-Myers Squibb Company330KUS$20.6M0.89%
Abbott Laboratories207KUS$20.5M0.89%
United Therapeutics Corporation36,491US$19.8M0.86%
Veradermics, Incorporated144KUS$17.5M0.76%
AnaptysBio, Inc.330KUS$16.6M0.72%
BioAge Labs, Inc.2.29MUS$16.3M0.71%
Arcus Biosciences, Inc.626KUS$16.2M0.70%
Edgewise Therapeutics, Inc.397KUS$16.1M0.70%
IDEXX Laboratories, Inc.29,145US$15.2M0.66%
Disc Medicine, Inc.232KUS$15.2M0.66%
Design Therapeutics, Inc.1.14MUS$14.4M0.63%
Biogen Inc.63,002US$14.2M0.62%
First Tracks Biotherapeutics, Inc.384KUS$13.6M0.59%
Nektar Therapeutics218KUS$13.2M0.57%
Definium Therapeutics, Inc.339KUS$12.9M0.56%
Nurix Therapeutics, Inc.524KUS$12.4M0.54%
Erasca, Inc.677KUS$9.93M0.43%
Tarsus Pharmaceuticals, Inc.110KUS$8.66M0.38%
Silence Therapeutics PLC212KUS$2.31M0.10%
Savara, Inc.356KUS$1.84M0.08%
Septerna, Inc.46,217US$1.81M0.08%
Mirum Pharmaceuticals, Inc.19,450US$1.66M0.07%
Sagimet Biosciences Inc. - Series A162KUS$1.6M0.07%
Phibro Animal Health Corporation43,216US$1.54M0.07%
Jade Biosciences, Inc.107KUS$1.51M0.07%
NextCure, Inc.223KUS$1.12M0.05%
Praxis Precision Medicines, Inc.3,703US$1.08M0.05%
Absci Corporation80,817US$870K0.04%
OnKure Therapeutics, Inc.313KUS$852K0.04%
Inventiva SA210KUS$773K0.03%
Tyra Biosciences, Inc.31,407US$687K0.03%
Aktis Oncology, Inc.31,605US$615K0.03%
Bolt Biotherapeutics, Inc.138KUS$507K0.02%
iBio, Inc.372KUS$439K0.02%
Lisata Therapeutics, Inc.156KUS$225K<0.01%
ImageneBio, Inc.31,884US$146K<0.01%
Cogent Biosciences, Inc.0US$00.00%
Gilead Sciences, Inc.0US$00.00%
Heartflow, Inc.0US$00.00%
Insmed Incorporated0US$00.00%
Sionna Therapeutics, Inc.0US$00.00%
Supernus Pharmaceuticals, Inc.0US$00.00%
Tenax Therapeutics, Inc.0US$00.00%

Source

Download original · View original at SEC

Related